Diana Dubrall

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 11

Top Topics

Angiotensin Converting Enzyme

Cross Sectional

Top Venues

BMC pharmacology & toxicology

British journal of clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Patrick Christ, Diana Dubrall, Katja Susanne Just, Britta Lewke, Maike Below, Julia Carolin Stingl, Matthias Schmid, Bernhardt Sachs
Identification and comparison of sex-specific serious adverse drug reactions in spontaneous reports and systematically collected reports (ADRED). British journal of clinical pharmacology (2023)
Patrick Christ, Diana Dubrall, Matthias Schmid, Bernhardt Sachs
Comparative Analysis of Information Provided in German Adverse Drug Reaction Reports Sent by Physicians, Pharmacists and Consumers. Drug safety (2023)
Bernhardt Sachs, Diana Dubrall, Klaus Kraywinkel, Maike Below, Matthias Schmid, Jens Bate, Wilma Fischer-Barth
Descriptive analysis of 179 German reports of melanoma reported to an adverse drug reaction database as a drug-related adverse effect, and comparison with melanoma cases contained in German cancer registries. Clinical and experimental dermatology 47 (6) (2022)
Diana Dubrall, Bernhardt Sachs, Klaus Kraywinkel, Maike Below, Matthias Schmid, Wilma Fischer-Barth, Jens Bate
Analyses of Basal and Squamous Cell Carcinoma Reported as an Adverse Drug Reaction and Comparison with Cases from the Cancer Registry from Germany. Drugs in R&D (2022)
Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Carolin Stingl, Patrick Christ, Ursula Köberle, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Adverse Drug Reactions in Children: Comparison of Reports Collected in a Pharmacovigilance Project Versus Spontaneously Collected ADR Reports. Paediatric drugs (2022)
Diana Dubrall, René Pflock, Joanna Kosinska, Matthias Schmid, Markus Bleich, Nina Himmerkus, Stefan Offermanns, Markus Schwaninger, Bernhardt Sachs
Do dimethyl fumarate and nicotinic acid elicit common, potentially HCA2 -mediated adverse reactions? A combined epidemiological-experimental approach. British journal of clinical pharmacology 87 (10) (2021)
Diana Dubrall, Sarah Leitzen, Irmgard Toni, Julia Carolin Stingl, M Schulz, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Descriptive analysis of adverse drug reaction reports in children and adolescents from Germany: frequently reported reactions and suspected drugs. BMC pharmacology & toxicology 22 (1) (2021)
Sarah Leitzen, Diana Dubrall, Irmgard Toni, Julia Stingl, Maike Schulz, Matthias Schmid, Antje Neubert, Bernhardt Sachs
Analysis of the reporting of adverse drug reactions in children and adolescents in Germany in the time period from 2000 to 2019. PloS one 16 (3) (2021)
Diana Dubrall, Katja S Just, Matthias Schmid, Julia C Stingl, Bernhardt Sachs
Adverse drug reactions in older adults: a retrospective comparative analysis of spontaneous reports to the German Federal Institute for Drugs and Medical Devices. BMC pharmacology & toxicology 21 (1) (2020)
Diana Dubrall, Matthias Schmid, Julia Carolin Stingl, Bernhardt Sachs
Angioedemas associated with renin-angiotensin system blocking drugs: Comparative analysis of spontaneous adverse drug reaction reports. PloS one 15 (3) (2020)
Bernhardt Sachs, Diana Dubrall, Wilma Fischer-Barth, Matthias Schmid, Julia Stingl
Drug-induced anaphylactic reactions in children: A retrospective analysis of 159 validated spontaneous reports. Pharmacoepidemiology and drug safety 28 (3) (2019)